JPWO2023229024A1 - - Google Patents

Info

Publication number
JPWO2023229024A1
JPWO2023229024A1 JP2024523357A JP2024523357A JPWO2023229024A1 JP WO2023229024 A1 JPWO2023229024 A1 JP WO2023229024A1 JP 2024523357 A JP2024523357 A JP 2024523357A JP 2024523357 A JP2024523357 A JP 2024523357A JP WO2023229024 A1 JPWO2023229024 A1 JP WO2023229024A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523357A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023229024A1 publication Critical patent/JPWO2023229024A1/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2024523357A 2022-05-27 2023-05-26 Pending JPWO2023229024A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022087037 2022-05-27
PCT/JP2023/019625 WO2023229024A1 (ja) 2022-05-27 2023-05-26 血液腫瘍の診断を補助する方法、血液腫瘍の診断を行うためのデータを得る方法、及びこれらの方法のためのキット

Publications (1)

Publication Number Publication Date
JPWO2023229024A1 true JPWO2023229024A1 (https=) 2023-11-30

Family

ID=88919405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523357A Pending JPWO2023229024A1 (https=) 2022-05-27 2023-05-26

Country Status (4)

Country Link
US (1) US20250093358A1 (https=)
EP (1) EP4535004A4 (https=)
JP (1) JPWO2023229024A1 (https=)
WO (1) WO2023229024A1 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010521979A (ja) * 2007-03-27 2010-07-01 ベルトルト・ケップリンガー キヌレニン変換酵素および／またはキヌレン酸、アントラニル酸および／または３−ヒドロキシキヌレニン−生成酵素の活性測定
JP2016533753A (ja) * 2013-08-30 2016-11-04 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 腫瘍の治療のための、キヌレニンを枯渇させる酵素の投与
JP2017519816A (ja) * 2014-05-29 2017-07-20 スプリング バイオサイエンス コーポレーション 抗インドールアミン２，３−ジオキシゲナーゼ１抗体及びその診断的使用
JP2020506895A (ja) * 2017-01-17 2020-03-05 ボード オブ レジェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System インドールアミン２，３−ジオキシゲナーゼおよび／またはトリプトファンジオキシゲナーゼの阻害剤として有用な化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2722672B1 (en) 2011-06-15 2019-02-20 Sanyo Chemical Industries, Ltd. Assay method using magnetic silica particles and reagent for said assay method
JP2018501202A (ja) 2014-11-19 2018-01-18 ネステク ソシエテ アノニム セロトニン、トリプトファン、及びキヌレニンの代謝産物に対する抗体及びその使用
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010521979A (ja) * 2007-03-27 2010-07-01 ベルトルト・ケップリンガー キヌレニン変換酵素および／またはキヌレン酸、アントラニル酸および／または３−ヒドロキシキヌレニン−生成酵素の活性測定
JP2016533753A (ja) * 2013-08-30 2016-11-04 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 腫瘍の治療のための、キヌレニンを枯渇させる酵素の投与
JP2017519816A (ja) * 2014-05-29 2017-07-20 スプリング バイオサイエンス コーポレーション 抗インドールアミン２，３−ジオキシゲナーゼ１抗体及びその診断的使用
JP2020506895A (ja) * 2017-01-17 2020-03-05 ボード オブ レジェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System インドールアミン２，３−ジオキシゲナーゼおよび／またはトリプトファンジオキシゲナーゼの阻害剤として有用な化合物

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DENZ H、外6名: "Weight loss in patients with hematological neoplasias is associated with immune system stimulation", THE CLINICAL INVESTIGATOR, vol. 71, no. 1, JPN6023033018, 1993, pages 37 - 41, ISSN: 0005775974 *
YIQUAN CHEN、外１名: "Kynurenine Pathway Metabolites in Humans: Disease and Healthy States", INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, vol. 2, JPN6023033019, 2009, pages 1 - 19, ISSN: 0005775973 *
ZDZISIDSKA B ET AL: "Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance", LEUKEMIA RESEARCH, vol. 34, no. 1, JPN6026000986, 1 January 2010 (2010-01-01), US, pages 38 - 45, ISSN: 0005775970 *
斉藤邦明、外2名: "トリプトファン代謝と疾患−生体防御と破壊−", 臨床化学, vol. 29, JPN6023033017, 2000, JP, pages 103 - 112, ISSN: 0005775972 *
正木彩子、外１９名: "成人Ｔ細胞白血病／リンパ腫におけるトリプトファン代謝の予後に関する意義", 臨床血液, vol. 56, no. 11, JPN6023033020, JP, pages 2295 - 2304, ISSN: 0005775971 *

Also Published As

Publication number Publication date
US20250093358A1 (en) 2025-03-20
EP4535004A1 (en) 2025-04-09
WO2023229024A1 (ja) 2023-11-30
EP4535004A4 (en) 2025-09-17

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
JPWO2023229024A1 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13138U (https=)
CN307046704S (https=)
BY13135U (https=)
BY13149U (https=)
BY13137U (https=)
CN307047634S (https=)
BY13139U (https=)
BY13140U (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260319